Treatment for Stress and Mixed Urinary Incontinence and Vaginal Vault Prolapse

Medtronic

Status

Completed

Conditions

Urinary Incontinence, Stress

Mixed Incontinence

Vaginal Vault Prolapse

Treatments

Device: Vaginal Sling

Study type

Interventional

Funder types

Industry

Identifiers

NCT00223106

WHC03001

Details and patient eligibility

About

The primary objective of this study is to further evaluate the safety and effectiveness of the use of a sling device in women for stress and mixed urinary incontinence as well as vaginal vault prolapse.

Full description

Urinary incontinence is the involuntary loss of urine and can affect both men and women throughout their lives. Women are more likely to develop incontinence as a result of pregnancy and childbirth. There are approximately 11 million cases of incontinence in the US contributing to several different types of incontinence including :

Urge - 30% of the market
Stress - 30% of the market of which 85% are women
Combination urge and stress - 40%

Despite advances in behavioral therapy, pharmacological advances as well as development of minimally invasive surgical procedures, only one out of every twelve people affected actually seek help.

Prolapse

Globally, approximately 1 million women suffer uterovaginal prolapse annually and this condition can be associated with urinary incontinence. The breakdown of treatments for uterovaginal prolapse includes:

20% - no treatment
20% - non surgical management (pessary)
60% - receive a surgical procedure of a suture repair or mesh repair

There were greater than 600,000 surgeries performed globally to treat prolapse. These numbers are projected to increase due to rapid, easy, and less costly methods as well as new products that facilitate the easier procedures.

Enrollment

467 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Subject must be female and >18 years of age.
Subject must have genuine stress or mixed incontinence AND/OR evidence of pelvic organ prolapse.

Exclusion criteria

Any subject with clotting defects, bleeding disorders or receiving anticoagulant treatments AND is determined to be at risk for minimally invasive surgery as determined by the investigator
Subjects who currently have an untreated urinary tract infection
Subject is unable to comply with the study requirements, follow-up schedule, or to give valid informed consent.
Subject is pregnant or desires future pregnancies.